Integra Lifesciences

Recent news

• Rating change
  Argus Research Upgrades Integra Lifesciences(IART.US) to Buy Rating, Announces Target Price $25
  Market Newswire · 2026/6/18
• Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating
  Market Newswire · 2026/10/5
• Citi Maintains Integra Lifesciences(IART.US) With Hold Rating, Maintains Target Price $19
  Market Newswire · 2026/8/13
• Rating change
  Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Cuts Target Price to $9
  Market Newswire · 2026/3/11
• Rating change
  Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $19
  Market Newswire · 2026/7/16
• BTIG Maintains Integra Lifesciences(IART.US) With Hold Rating
  Market Newswire · 2026/10/3
• Rating change
  Argus Research Downgrades Integra Lifesciences(IART.US) to Hold Rating
  Market Newswire · 2026/4/15
• Citi Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $15
  Market Newswire · 2026/10/5
• Rating change
  Wells Fargo Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $15
  Market Newswire · 2026/5/6
• Rating change
  Citi Upgrades Integra Lifesciences(IART.US) to Hold Rating, Raises Target Price to $16
  Market Newswire · 2026/5/28
• Rating change
  Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Raises Target Price to $11
  Market Newswire · 2026/5/6
• Rating change
  BofA Securities Initiates Integra Lifesciences(IART.US) With Sell Rating
  Market Newswire · 2026/5/14
• Rating change
  BMO Capital Maintains Integra Lifesciences(IART.US) With Hold Rating, Announces Target Price $19
  Market Newswire · 2026/7/10
• Rating change
  Analysts Offer Insights on Healthcare Companies: Kairos Pharma, Ltd. (KAPA), Integra Lifesciences (IART) and Biogen (BIIB)
  TipRanks · 2026/5/14
• Rating change
  BMO Capital Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $18
  Market Newswire · 2026/7/30
• Rating change
  Citi Maintains Integra Lifesciences(IART.US) With Sell Rating, Maintains Target Price $9
  Market Newswire · 2026/4/7
• Rating change
  Wells Fargo Maintains Integra Lifesciences(IART.US) With Hold Rating, Raises Target Price to $18
  Market Newswire · 2026/7/30
• Rating change
  Wells Fargo Downgrades Integra Lifesciences(IART.US) to Hold Rating, Cuts Target Price to $12
  Market Newswire · 2026/3/18
• Rating change
  Truist Financial Maintains Integra Lifesciences(IART.US) With Hold Rating, Cuts Target Price to $12
  Market Newswire · 2026/4/15
• J.P. Morgan Maintains Integra Lifesciences(IART.US) With Sell Rating, Raises Target Price to $17
  Market Newswire · 2026/8/5

Headlines are aggregated automatically and are not independently verified or edited by our team.